SCHEMBL7569205

SCHEMBL7569205

CCC(=O)OCCCCCC(=O)O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.67
ALDH1A1 P00352 3/20 0.57
HTT P42858 1/20 0.53
GPR84 Q9NQS5 7/20 0.52
PPARG P37231 7/20 0.52
PPARD Q03181 7/20 0.52
PPARA Q07869 7/20 0.52
HDAC11 Q96DB2 5/20 0.52
TSHR P16473 5/20 0.52
PTPN1 P18031 3/20 0.52
TLR2 O60603 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
FABP4 P15090 2/20 0.52
SLC22A6 Q4U2R8 1/20 0.52
SLC22A8 Q8TCC7 1/20 0.52
MEN1 O00255 1/20 0.52
ESR1 P03372 1/20 0.52
ALOX15 P16050 1/20 0.52
PDE4A P27815 1/20 0.52
KMT2A Q03164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10599272 1.00 NAAA (0.67) NAAAALDH1A1HTTGPR84PPARG
SCHEMBL3503492 1.00 NAAA (0.67) NAAAALDH1A1HTTGPR84PPARG
SCHEMBL11907721 1.00 NAAA (0.67) NAAAALDH1A1HTTGPR84PPARG
SCHEMBL11909112 1.00 NAAA (0.67) NAAAALDH1A1HTTGPR84PPARG
SCHEMBL11909789 1.00 NAAA (0.67) NAAAALDH1A1HTTGPR84PPARG
SCHEMBL14354798 0.98 NAAA (0.63) NAAAALDH1A1HTTGPR84PPARG
SCHEMBL16664628 0.96 NAAA (0.62) NAAAALDH1A1HTTGPR84PPARG
SCHEMBL727436 0.91 NAAA (0.59) NAAAALDH1A1HTTGPR84PPARG
Octanoic Acid SCHEMBL11421609 0.90 NAAA (0.71) NAAAALDH1A1GPR84PPARGPPARD
SCHEMBL3993048 0.87 NAAA (0.86) NAAAHTTTSHRDGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150021528-A1 SOLUBLE FUNCTIONALIZED NANOPARTICLES FOR USE IN OPTICAL MATERIALS STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF UNIVERSITY (US) 2015-01-22 US claimed
US-20020038046-A1 Method for the purification of N-[N-(3,3-Dimethylbutyl)-L-a-Aspartyl]-L-Phenylalanine 1-Methyl Ester NUTRASWEET PROPERTY HOLDINGS, INC. 2002-03-28 US claimed
WO-2001009168-A1 A METHOD FOR THE PURIFICATION OF N-[N-(3,3-DIMETHYLBUTYL)-L-α-ASPARTYL]-L-PHENYLALANINE 1-METHYL ESTER THE NUTRASWEET COMPANY (US) 2001-02-08 WO claimed
EP-0177807-B1 HEXANOATES, PROCESS FOR THEIR PREPARATION AND PERFUMES AND/OR FLAVOURING AGENTS HAVING A CONTENT OF SUCH COMPOUNDS L. GIVAUDAN & CIE Société Anonyme (CH) 1989-03-15 EP claimed
US-20250179324-A1 LIQUID COMPSITION, INSULATING RESIN LAYER, ELECTRODE FOR ELECTROCHEMICAL ELEMENT, ELECTRODE LAMINATE, ELECTROCHEMICAL ELEMENT, AND METHOD OF MANUFACTURING ELECTRODE LAMINATE RICOH COMPANY, LTD. (JP) 2025-06-05 US disclosed
US-20250182925-A1 LAMINATE FOR SOLID STATE ELECTROCHEMICAL ELEMENT, SOLID STATE ELECTROCHEMICAL ELEMENT, ELECTRIC DEVICE, AND MOBILE OBJECT RICOH COMPANY, LTD. (JP) 2025-06-05 US disclosed
US-9513406-B2 Soluble functionalized nanoparticles for use in optical materials UNIVERSITY OF OREGON (US) 2016-12-06 US disclosed
US-20150023643-A1 GRADIENT OPTICAL POLYMER NANOCOMPOSITES State of Oregon acting by and through the State Board of Higher Education on behalf of the Univers (US) 2015-01-22 US disclosed
US-20150021528-A1 SOLUBLE FUNCTIONALIZED NANOPARTICLES FOR USE IN OPTICAL MATERIALS STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF UNIVERSITY (US) 2015-01-22 US disclosed
US-8628685-B2 Mesogen-containing compounds TRANSITIONS OPTICAL, INC (US) 2014-01-14 US disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020038046-A1 Method for the purification of N-[N-(3,3-Dimethylbutyl)-L-a-Aspartyl]-L-Phenylalanine 1-Methyl Ester DNPEP, ANPEP, ASPH NAAA 78/4885ALDH1A1 1977/4885HTT 1096/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.